Athyrium Capital Management as of Dec. 31, 2022
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Sponsored ADS | 27.2 | $65M | 8.9M | 7.30 | |
| Biora Note 7.250% 12/0 (Principal) | 23.6 | $56M | 104M | 0.54 | |
| Omeros Corp Note 5.250% 2/1 (Principal) | 13.3 | $32M | 58M | 0.55 | |
| Omeros Corp Note 6.250%11/1 (Principal) | 8.5 | $20M | 21M | 0.96 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 6.9 | $16M | 15M | 1.12 | |
| Caremax Com Cl A | 6.9 | $16M | 4.5M | 3.65 | |
| Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) | 3.5 | $8.2M | 9.0M | 0.91 | |
| BridgeBio Pharma Note 2.250% 2/0 (Principal) | 3.3 | $7.8M | 20M | 0.39 | |
| Puma Biotechnology (PBYI) | 3.2 | $7.6M | 1.8M | 4.23 | |
| Progenity | 2.3 | $5.6M | 42M | 0.13 | |
| Recro Pharma (SCTL) | 1.4 | $3.3M | 2.2M | 1.49 |
